Stockholm, Sweden - Neko Health, a Swedish health-tech company focused on preventive measures and early detection, announced today the successful completion of its Series A funding round, raising an impressive $65.4 million. The round was led by prominent venture capital firms General Catalyst, Atomico, and Lakestar.

Neko Health, co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek, aims to transform the healthcare system by reimagining the patient's experience and integrating cutting-edge advancements in sensors and artificial intelligence. With a clear vision to empower individuals to maintain their well-being, Neko Health has developed a groundbreaking medical scanning technology concept that enables broad and non-invasive health data collection, while maintaining convenience and affordability for the public.

"We are glad to have the support of such distinguished investors like General Catalyst, Atomico, and Lakestar," said Daniel Ek, Co-Founder of Neko Health. "This funding round will enable us to continue pioneering innovative solutions that reshape the healthcare landscape and ultimately benefit individuals worldwide. We are committed to leveraging advanced technology to make healthcare more accessible and effective."